BCL-2, in combination with MVP and IGF-1R expression, improves prediction of clinical outcome in complete response cervical carcinoma patients treated by radiochemotherapy

Gynecologic Oncology

Volumn 122, Issue 3, 2011, Pages 585-589

  Henríquez Hernández, Luis Alberto ^a,b,c   Lloret, Marta ^a,b,c   Pinar, Beatriz ^a,b,c   Bordón, Elisa ^a,b,c   Rey, Agustín ^a   Lubrano, Amina ^d   Lara, Pedro Carlos ^a,b,c  

^a HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^b Madrid Spain   (Spain)

^c UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^d HOSPITAL UNIVERSITARIO MATERNO INFANTIL DE CANARIAS   (Spain)

Author keywords

BCL 2; Cervical cancer; IGF 1R; Ku70 80; Major vault protein (MVP)

Indexed keywords

CISPLATIN; KI 67 ANTIGEN; LUNG RESISTANCE PROTEIN; PROTEIN BCL 2; PROTEIN P53; SOMATOMEDIN C RECEPTOR;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CAUSE SPECIFIC SURVIVAL; CHEMORADIOTHERAPY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RADIATION DOSE; TREATMENT OUTCOME; TREATMENT RESPONSE; UTERINE CERVIX CARCINOMA;

ADULT; AGED; ANTIGENS, NUCLEAR; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, IGF TYPE 1; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 80051550628     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.05.037     Document Type: Article

References (34)

1. M.L. Looi, A.Z. Dali, S.A. Ali, W.Z. Ngah, and Y.A. Yusof Expression of p53, bcl-2 and Ki-67 in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix Anal Quant Cytol Histol 30 2008 63 70 (Pubitemid 351501865)
2. S.K. Mishra, and J.A. Crasta An immunohistochemical comparison of P53 and Bcl-2 as apoptotic and MIB1 as proliferative markers in low-grade and high-grade ovarian serous carcinomas Int J Gynecol Cancer 20 2010 537 541
3. N. Sun, Q. Meng, and A. Tian Expressions of the anti-apoptotic genes Bag-1 and Bcl-2 in colon cancer and their relationship Am J Surg 200 2010 341 345
4. S.J. Dawson, N. Makretsov, F.M. Blows, K.E. Driver, E. Provenzano, and J. Le Quesne BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received Br J Cancer 103 2010 668 675
5. A. Haimovitz-Friedman, R.N. Kolesnick, and Z. Fuks Modulation of the apoptotic response: potential for improving the outcome in clinical radiotherapy Semin Radiat Oncol 6 1996 273 283 (Pubitemid 26367394)
6. C.B. Thompson Apoptosis in the pathogenesis and treatment of disease Science 267 1995 1456 1462
7. V. Wootipoom, N. Lekhyananda, T. Phungrassami, P. Boonyaphiphat, and P. Thongsuksai Prognostic significance of Bax, Bcl-2, and p53 expressions in cervical squamous cell carcinoma treated by radiotherapy Gynecol Oncol 94 2004 636 642 (Pubitemid 39194454)
8. A.D. Amsel, M. Rathaus, N. Kronman, and H.Y. Cohen Regulation of the proapoptotic factor Bax by Ku70-dependent deubiquitylation Proc Natl Acad Sci USA 105 2008 5117 5122 (Pubitemid 351738519)
9. Q. Wang, F. Gao, W.S. May, Y. Zhang, T. Flagg, and X. Deng Bcl2 negatively regulates DNA double-strand-break repair through a nonhomologous end-joining pathway Mol Cell 29 2008 488 498 (Pubitemid 351282542)
10. M. Lloret, P.C. Lara, E. Bordon, F. Fontes, A. Rey, and B. Pinar Major vault protein may affect nonhomologous end-joining repair and apoptosis through Ku70/80 and Bax downregulation in cervical carcinoma tumors Int J Radiat Oncol Biol Phys 73 2009 976 979
11. E. Steiner, K. Holzmann, L. Elbling, M. Micksche, and W. Berger Cellular functions of vaults and their involvement in multidrug resistance Curr Drug Targets 7 2006 923 934
12. P. Silva, C.M. West, N. Slevin, H. Valentine, W.D. Ryder, and L. Hampson Tumor expression of major vault protein is an adverse prognostic factor for radiotherapy outcome in oropharyngeal carcinoma Int J Radiat Oncol Biol Phys 69 2007 133 140 (Pubitemid 47247499)
13. N.L. Kedersha, J.E. Heuser, D.C. Chugani, and L.H. Rome Vaults. III. Vault ribonucleoprotein particles open into flower-like structures with octagonal symmetry J Cell Biol 112 1991 225 235 (Pubitemid 21909613)
14. H.P. Rodemann, K. Dittmann, and M. Toulany Radiation-induced EGFR-signaling and control of DNA-damage repair Int J Radiat Biol 83 2007 781 791 (Pubitemid 350219102)
15. S.J. Ryu, H.J. An, Y.S. Oh, H.R. Choi, M.K. Ha, and S.C. Park On the role of major vault protein in the resistance of senescent human diploid fibroblasts to apoptosis Cell Death Differ 15 2008 1673 1680
16. H.J. An, S.J. Ryu, S.Y. Kim, H.R. Choi, J.H. Chung, and S.C. Park Age associated high level of major vault protein is p53 dependent Cell Biochem Funct 27 2009 289 295
17. H. Hochegger, D. Dejsuphong, T. Fukushima, C. Morrison, E. Sonoda, and V. Schreiber Parp-1 protects homologous recombination from interference by Ku and Ligase IV in vertebrate cells EMBO J 25 2006 1305 1314
18. M. Lloret, P.C. Lara, E. Bordon, A. Rey, O. Falcon, and R.M. Apolinario MVP expression is related to IGF1-R in cervical carcinoma patients treated by radiochemotherapy Gynecol Oncol 110 2008 304 307
19. M. Lloret, P.C. Lara, E. Bordon, B. Pinar, A. Rey, and O. Falcon IGF-1R expression in localized cervical carcinoma patients treated by radiochemotherapy Gynecol Oncol 106 2007 8 11 (Pubitemid 46901080)
20. R. Baserga, F. Peruzzi, and K. Reiss The IGF-1 receptor in cancer biology Int J Cancer 107 2003 873 877 (Pubitemid 37429826)
21. American Cancer Society, American College of Surgeons, American Society of Clinical Oncology, Centers for Disease Control, Prevention, International Union Against Cancer, and American Joint Committee on Cancer AJCC cancer staging manual 7th ed. 2010 Springer New York
22. P. Therasse, S.G. Arbuck, E.A. Eisenhauer, J. Wanders, R.S. Kaplan, and L. Rubinstein New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 2000 205 216
23. N.C. Teoh, Y.Y. Dan, K. Swisshelm, S. Lehman, J.H. Wright, and J. Haque Defective DNA strand break repair causes chromosomal instability and accelerates liver carcinogenesis in mice Hepatology 47 2008 2078 2088 (Pubitemid 351945574)
24. M. Wang, W. Wu, B. Rosidi, L. Zhang, H. Wang, and G. Iliakis PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways Nucleic Acids Res 34 2006 6170 6182 (Pubitemid 44942738)
25. W.Y. Mansour, T. Rhein, and J. Dahm-Daphi The alternative end-joining pathway for repair of DNA double-strand breaks requires PARP1 but is not dependent upon microhomologies Nucleic Acids Res 38 2010 6065 6077
26. D. Dornan, H. Shimizu, A. Mah, T. Dudhela, M. Eby, and K. O'Rourke ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage Science 313 2006 1122 1126 (Pubitemid 44300238)
27. M.A. Pavon, M. Parreno, X. Leon, F.J. Sancho, M.V. Cespedes, and I. Casanova Ku70 predicts response and primary tumor recurrence after therapy in locally advanced head and neck cancer Int J Cancer 123 2008 1068 1079
28. K.D. Brown, T.A. Lataxes, S. Shangary, J.L. Mannino, J.F. Giardina, and J. Chen Ionizing radiation exposure results in up-regulation of Ku70 via a p53/ataxia-telangiectasia-mutated protein-dependent mechanism J Biol Chem 275 2000 6651 6656 (Pubitemid 30129968)
29. X. Tian, G. Chen, H. Xing, D. Weng, Y. Guo, and D. Ma The relationship between the down-regulation of DNA-PKcs or Ku70 and the chemosensitization in human cervical carcinoma cell line HeLa Oncol Rep 18 2007 927 932
30. E. Kim, S. Lee, M.F. Mian, S.U. Yun, M. Song, and K.S. Yi Crosstalk between Src and major vault protein in epidermal growth factor-dependent cell signalling FEBS J 273 2006 793 804
31. T. Minaguchi, K.A. Waite, and C. Eng Nuclear localization of PTEN is regulated by Ca(2+) through a tyrosil phosphorylation-independent conformational modification in major vault protein Cancer Res 66 2006 11677 11682 (Pubitemid 46094179)
32. Z. Xiang, W. Yuan, N. Luo, Y. Wang, K. Tan, and Y. Deng A novel human zinc finger protein ZNF540 interacts with MVP and inhibits transcriptional activities of the ERK signal pathway Biochem Biophys Res Commun 347 2006 288 296 (Pubitemid 44026490)
33. M.M. Green, G.J. Hutchison, H.R. Valentine, R.J. Fitzmaurice, S.E. Davidson, and R.D. Hunter Expression of the proapoptotic protein Bid is an adverse prognostic factor for radiotherapy outcome in carcinoma of the cervix Br J Cancer 92 2005 449 458 (Pubitemid 40395525)
34. B. Mukherjee, H. Choy, C. Nirodi, and S. Burma Targeting nonhomologous end-joining through epidermal growth factor receptor inhibition: rationale and strategies for radiosensitization Semin Radiat Oncol 20 2010 250 257